1[1]Reiter R J.Oxidative damage in the central nervous systerm:protecoin by melatonin [J].Prog Neurobio,1999,57(2):300-301. 被引量：1
2[2]Pelson G D,Haris G J,poers R E,et al.Quantitative changes in mesial temporal volrme regionak :bral blood flow and cognition in Alzheimer's disease[J].Arch Gen psychiatry,1992,49(4):400-402. 被引量：1
3[3]Gonzalez R G,Alan J F,Alzheimer R G,et al.Fauctional MR in the evaluazion of dementia : Correlation of abnomal dynamic cerebaral in cerebral metabolism on positron emission tomography with fludeoxgoucosi F18[J].AJNR,1995,16(3):759-763. 被引量：1
4[4]Tohgi H,yonezawa H,Takahashi S,et al.cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementis with deep white matter changes[J].Neuroradiology,1998,40(1):130-131. 被引量：1
6[6]De Ferrani G V,Von Bernhardi R.Calderon F H,et al.Responses induced by tacrine neuronal and non-enuronal cell Lines[J].I Nerurasci Res,1998,52(7):430-435. 被引量：1
7[7]Davis K L,powchis P.Tacrine [J].Cancte,1995,89(50):625-630. 被引量：1
8[8]Tang X C.Huperzine A.(shuangyiping):a promising drug for Alzheimer's disease [J],Acta Pharmacol Sina,1996,17(6):481-484. 被引量：1
9[9]Raskind M A,Peskind E R,Wessel T,et al.Galantamine in AD:A 6-month randomized,placebo-controlled trial with a 6-month extension.The Galantamine USA-1 Study Group[J].Neurology,2000,54(12):2261-2268. 被引量：1
10[10]Koges J,kirby L C,Hempelman S R,et al.Clinical trial of indomethacin in Alzheimer's disease[J].Neurology,1993,43(8):1609-1611. 被引量：1
